G01N 2333/595
Gastrins
Official title: Gastrins; Cholecystokinins [CCK]
G01N2333/595 (Gastrins) appears on 29 US grants and 41 published applications in this corpus.
Search patents in G01N- Granted patents
- 29
- Published applications
- 41
- Assignees
- 23
- Inventors
- 60
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 1 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 1 | 4 |
| 2008 | 1 | 3 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 6 |
| 2012 | 1 | 2 |
| 2013 | 1 | 0 |
| 2014 | 3 | 1 |
| 2015 | 1 | 2 |
| 2016 | 2 | 0 |
| 2017 | 1 | 4 |
| 2018 | 0 | 1 |
| 2019 | 5 | 4 |
| 2020 | 1 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 1 |
| 2023 | 3 | 0 |
| 2024 | 2 | 3 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Compositions and methods for detecting and treating gastric cancer18 Nov 2025US 12,474,343 B2Progastrine et Cancers S.À R.L.
- Compositions and methods for assessing the risk of cancer occurrence24 Dec 2024US 12,174,195 B2Syncerus S.À R.L.
- Compositions and methods for detecting lung cancer27 Feb 2024US 11,913,958 B2ECS-Progastrin SA
- Compositions and methods for detecting and treating esophageal cancer17 Oct 2023US 11,789,021 B2Progastrine et Cancers S.À R.L.
- Compositions and methods for detecting and treating ovarian cancer19 Sep 2023US 11,760,808 B2Progastrine et Cancers S.À R.L.
- Compositions and methods for detecting and treating gastric cancer5 Dec 2024US 2024/0402181 A1Progastrine et Cancers S.À R.L.
- Compositions and methods for detecting and treating esophageal cancer14 Mar 2024US 2024/0085423 A1Progastrine et Cancers S.À R.L.
- Compositions and methods for detecting and treating ovarian cancer18 Jan 2024US 2024/0018264 A1Progastrine et Cancers S.À R.L.
- Monoclonal antibodies to progastrin and their uses23 Jun 2022US 2022/0195035 A1Centre National de la Recherche Scientifique (CNRS)
- Compositions and methods for assessing the risk of cancer occurrence2 Dec 2021US 2021/0373027 A1Syncerus S.À R.L.
Most cited
By later US patents
- Inactivation of enzymes57US 4,483,922 AAMF Incorporated · 1984
- Monoclonal antibodies to progastrin15US 8,158,128 B2Cancer Advances Inc. · 2012
- Method for assessing the risk of peptic ulcer, comprising the steps of determining quantitatively the concentrations of pepsinogen I (PGI) and gastrin-17 in a serum sample9US 6,872,543 B1Biohit Oyj · 2005
- Gastrin hormone immunoassays8US 7,235,376 B2Receptor Biologix, Inc. · 2007
- Method for diagnosing atrophic gastritis5US 7,358,062 B2Biohit Oyj · 2008